Papua New Guinea receives 146,000 doses of the Oxford-AstraZeneca COVID-19 vaccine from New Zealand, facilitated through the COVAX initiative
Papua New Guinea receives 146,000 doses of the Oxford-AstraZeneca COVID-19 vaccine from New Zealand, facilitated through the COVAX initiative.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthPapua New Guinea receives 146,000 doses of the Oxford-AstraZeneca COVID-19 vaccine from New Zealand, facilitated through the COVAX initiative
View Premium plansBrowse free archive reportsPapua New Guinea receives 146,000 doses of the Oxford-AstraZeneca COVID-19 vaccine from New Zealand, facilitated through the COVAX initiative.